Antitumor Activity of 5-Aryl-2, 3-dihydroimidazo [2, 1-a] isoquinolines
WJ Houlihan, PG Munder, DA Handley…
Index: Houlihan, William J.; Munder, Paul G.; Handley, Dean A.; Cheon, Seung H.; Parrino, Vincent A. Journal of Medicinal Chemistry, 1995 , vol. 38, # 2 p. 234 - 240
Full Text: HTML
Citation Number: 39
Abstract
A series of 5-aryl-2, 3-dihydroimidazo [2, l-ulisoquinolines previously reported to be platelet activating factor (PAF) receptor antagonists were evaluated for potential antitumor activity. Several compounds, such as the 5-(4 '-tert-butylphenyl)(65), 5-[4 '-(trimethylsilyl) phenyll (69), and 5-(4 '-cyclohexylphenyl)(71) analogs showed very good cytotoxicity against several tumor cell lines. 5-[4'-(Piperidinomethyl) phenyll-2, 3-dihydroimidazo [2, l- ...
Related Articles:
Zeolite??catalyzed simple synthesis of different heterocyclic rings, part 2
[Hegedues, Adrienn; Vigh, Ilona; Hell, Zoltan Heteroatom Chemistry, 2004 , vol. 15, # 6 p. 428 - 431]
One-pot synthesis of imidazolines from aldehydes: detailed study about solvents and substrates
[Fujioka, Hiromichi; Murai, Kenichi; Kubo, Ozora; Ohba, Yusuke; Kita, Yasuyuki Tetrahedron, 2007 , vol. 63, # 3 p. 638 - 643]